Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 BRAF Mutation and Thyroid Cancer Recurrence.

Literature DB >> 26124474

BRAF Mutation and Thyroid Cancer Recurrence.

Mingzhao Xing¹.

Abstract

Entities: Gene

Mesh：

Substances：

Year: 2015 PMID： 26124474 DOI： 10.1200/JCO.2015.61.4016

Source DB: PubMed Journal: J Clin Oncol ISSN： 0732-183X Impact factor: 44.544

Keyword Cloud
Cited

× No keyword cloud information.

7 in total

1. Correlations of IGF-1R and COX-2 Expressions with Ras and BRAF Genetic Mutations, Clinicopathological Features and Prognosis of Colorectal Cancer Patients.

Authors: Mei Jin; Zi-Wen Long; Jing Yang; Xiang Lin
Journal: Pathol Oncol Res Date: 2017-02-10 Impact factor: 3.201

2. TERT Promoter Mutations Are Enriched in Oral Cavity Cancers and Associated With Locoregional Recurrence.

Authors: Yao Yu; Dan Fan; Xinmao Song; Kaveh Zakeri; Linda Chen; Jung Kang; Sean McBride; C Jillian Tsai; Lara Dunn; Eric Sherman; Nora Katabi; Snjezana Dogan; Jennifer Cracchiolo; Marc Cohen; Jay O Boyle; Mark Lee; Cristina Valero; Jingming Wang; Richard Wong; Luc Morris; Nadeem Riaz; Nancy Lee
Journal: JCO Precis Oncol Date: 2021-08-05

Review 3. Current Advances in Thyroid Cancer Management. Are We Ready for the Epidemic Rise of Diagnoses?

Authors: Dagmara Rusinek; Ewa Chmielik; Jolanta Krajewska; Michal Jarzab; Malgorzata Oczko-Wojciechowska; Agnieszka Czarniecka; Barbara Jarzab
Journal: Int J Mol Sci Date: 2017-08-22 Impact factor: 5.923

4. Co-existence of BRAF^V600E and TERT promoter mutations in papillary thyroid carcinoma is associated with tumor aggressiveness, but not with lymph node metastasis.

Authors: Haoyu Ren; Yifan Shen; Daixing Hu; Wei He; Jing Zhou; Yijia Cao; Yu Mao; Yi Dou; Wei Xiong; Qi Xiao; Yuhong Zhang; Xinliang Su
Journal: Cancer Manag Res Date: 2018-05-03 Impact factor: 3.989

BRAF Mutation and Thyroid Cancer Recurrence.

1. Correlations of IGF-1R and COX-2 Expressions with Ras and BRAF Genetic Mutations, Clinicopathological Features and Prognosis of Colorectal Cancer Patients.

2. TERT Promoter Mutations Are Enriched in Oral Cavity Cancers and Associated With Locoregional Recurrence.

Review 3. Current Advances in Thyroid Cancer Management. Are We Ready for the Epidemic Rise of Diagnoses?

4. Co-existence of BRAF^V600E and TERT promoter mutations in papillary thyroid carcinoma is associated with tumor aggressiveness, but not with lymph node metastasis.

5. Ultrasound-guided implantation of radioactive ¹²⁵I seed in radioiodine refractory differentiated thyroid carcinoma.

Review 6. Selective use of sorafenib in the treatment of thyroid cancer.

Review 7. Sonic Hedgehog Signaling in Thyroid Cancer.

BRAF Mutation and Thyroid Cancer Recurrence.

1. Correlations of IGF-1R and COX-2 Expressions with Ras and BRAF Genetic Mutations, Clinicopathological Features and Prognosis of Colorectal Cancer Patients.

2. TERT Promoter Mutations Are Enriched in Oral Cavity Cancers and Associated With Locoregional Recurrence.

Review 3. Current Advances in Thyroid Cancer Management. Are We Ready for the Epidemic Rise of Diagnoses?

4. Co-existence of BRAFV600E and TERT promoter mutations in papillary thyroid carcinoma is associated with tumor aggressiveness, but not with lymph node metastasis.

5. Ultrasound-guided implantation of radioactive 125I seed in radioiodine refractory differentiated thyroid carcinoma.

Review 6. Selective use of sorafenib in the treatment of thyroid cancer.

Review 7. Sonic Hedgehog Signaling in Thyroid Cancer.

4. Co-existence of BRAF^V600E and TERT promoter mutations in papillary thyroid carcinoma is associated with tumor aggressiveness, but not with lymph node metastasis.

5. Ultrasound-guided implantation of radioactive ¹²⁵I seed in radioiodine refractory differentiated thyroid carcinoma.